1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > HPV Testing & Pap Test Market by Test Type, by Application, by End User - Global Forecast to 2020

Increasing awareness of cervical cancer screening programs, and government initiative and funding are the Major Drivers of the HPV testing and Pap test Market
On the basis of test type, the HPV testing and Pap test market is divided into two major segments, namely, HPV testing and Pap test. The HPV testing segment is further classified into three sub-segments, namely, follow-up HPV testing, co-testing, HPV primary testing. The Pap test segment is expected to account for the largest share of the HPV testing and Pap test market in 2015. But this segment is projected to decline at a negative during the forecast period due to due the shift towards the use of HPV testing, as it provides enhanced accuracy and sensitivity than Pap test. Furthermore, the HPV testing segment is expected to grow at the highest CAGR in the next five years, owing to increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.

On the basis of type of application, the global HPV testing and Pap test market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.

On the basis of type of end user, the HPV testing and Pap test market is classified into three segments, namely, hospitals, laboratories, physicians’ offices and clinics. The laboratories end-user segment is expected to account for the largest share of the HPV testing and Pap test market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in shorter period of time.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data of the various segments in this industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives by governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on the key players in the HPV testing and Pap test market and the strategies adopted by them to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on cervical cancer screening tests offered by top 10 players in the HPV testing and Pap test market. The report analyzes the HPV testing and Pap test market by product, application, and end user across geographies

- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the HPV testing and Pap test market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for HPV testing and Pap test across geographies

- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the HPV testing and Pap test market

- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the HPV testing and Pap test market

Table Of Contents

HPV Testing and Pap Test Market by Test Type, by Application, by End User - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 STUDY SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 MARKET SIZE ESTIMATION 17
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 19
2.2.1 KEY DATA FROM SECONDARY SOURCES 20
2.2.2 KEY DATA FROM PRIMARY SOURCES 21
2.2.2.1 Key Industry Insights 22
2.2.3 ASSUMPTIONS 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 26
4.1 HPV TESTING AND PAP TEST MARKET OVERVIEW 26
4.2 HPV TESTING AND PAP TEST MARKET, BY TEST TYPE 26
4.3 HPV TESTING MARKET, BY TEST TYPE AND END USER 27
4.4 HPV TESTING AND PAP TEST MARKET, BY REGION 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 29
5.2 MARKET SEGMENTATION 30
5.3 MARKET DYNAMICS 31
5.3.1 DRIVERS 32
5.3.1.1 Increasing number of cervical cancer cases and growing aging population 32
5.3.1.2 Increasing awareness of cervical cancer screening programs 33
5.3.1.3 Government initiatives and funding 33
5.3.2 RESTRAINTS 34
5.3.2.1 Changes in regulatory guidelines for cervical cancer screening 34
5.3.2.2 HPV Vaccination 34
5.3.3 OPPORTUNITY 35
5.3.3.1 Introduction of HPV primary screening tests 35
5.3.4 CHALLENGE 36
5.3.4.1 Uncertain reimbursement scenario 36
6 HPV TESTING AND PAP TEST MARKET, BY TEST TYPE 37
6.1 INTRODUCTION 38
6.2 HPV TESTING 39
6.3 FOLLOW-UP HPV TESTING 43
6.4 CO-TESTING 44
6.5 PRIMARY HPV TESTING 44
6.6 PAP TEST 45
7 PAP TEST MARKET, BY APPLICATION 47
7.1 INTRODUCTION 48
7.1.1 CERVICAL CANCER SCREENING 49
7.1.2 VAGINAL CANCER SCREENING 51
8 HPV TESTING AND PAP TEST MARKET, BY END USER 53
8.1 INTRODUCTION 54
8.2 LABORATORIES 55
8.3 HOSPITALS 57
8.4 PHYSICIANS' OFFICES AND CLINICS 59
9 HPV TESTING AND PAP TEST MARKET, BY REGION 61
9.1 INTRODUCTION 62
9.2 NORTH AMERICA 65
9.2.1 U.S. 70
9.2.2 CANADA 72
9.3 EUROPE 75
9.4 ASIA-PACIFIC 80
9.4.1 JAPAN 82
9.4.2 CHINA 84
9.4.3 INDIA 85
9.4.4 REST OF ASIA-PACIFIC 87
9.5 REST OF THE WORLD 89
10 COMPETITIVE LANDSCAPE 92
10.1 OVERVIEW 92
10.2 MARKET SHARE ANALYSIS, GLOBAL HPV TESTING AND PAP TEST MARKET 93
10.2.1 PRODUCT APPROVALS AND LICENSES 95
10.2.2 NEW PRODUCT LAUNCHES 96
10.2.3 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 97
10.2.4 ACQUISITIONS 98
10.2.5 EXPANSIONS 99
11 COMPANY PROFILE 100
(Overview, Products and Services, Financials, Strategy and Development)*
11.1 INTRODUCTION 100
11.2 ABBOTT LABORATORIES 101
11.3 QIAGEN N.V. 103
11.4 ROCHE DIAGNOSTICS 106
11.5 HOLOGIC, INC. 108
11.6 BECTON, DICKINSON AND COMPANY 111
11.7 QUEST DIAGNOSTICS 113
11.8 ONCO HEALTH CORPORATION 115
11.9 SEEGENE, INC. 116
11.10 FEMASYS INC. 118
11.11 ARBOR VITA CORPORATION 119
*Details on Overview, Products and Services, Financials, Strategy and Development might not be Captured in case of Unlisted Companies.
12 APPENDIX 120
12.1 INSIGHTS OF INDUSTRY EXPERTS 120
12.2 DISCUSSION GUIDE 120
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 122
12.4 AVAILABLE CUSTOMIZATIONS 123
12.5 RELATED REPORTS 124
LIST OF TABLES

TABLE 1 INCREASING NUMBER OF CERVICAL CANCER CASES AND GROWING AGING POPULATION DRIVE THE HPV TESTING AND PAP TEST MARKET 34
TABLE 2 CHANGES IN REGULATORY GUIDELINES FOR CERVICAL CANCER SCREENING ACTS A RESTRAINING FACTOR HAMPERING THE MARKET GROWTH 35
TABLE 3 INTRODUCTION OF HPV PRIMARY SCREENING TESTS PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR THE HPV TESTING AND PAP TEST MARKET 36
TABLE 4 UNCERTAIN REIMBURSEMENT SCENARIO IS LIMITING THE GROWTH FOR THE HPV TESTING AND PAP TEST MARKET 36
TABLE 5 HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 39
TABLE 6 HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (MILLION TESTS) 39
TABLE 7 HPV TESTING MARKET SIZE, BY TEST TYPE, 2013-2020 (USD MILLION) 40
TABLE 8 HPV TESTING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 41
TABLE 9 HPV TESTING MARKET SIZE, BY REGION, 2013-2020 (MILLION TESTS) 42
TABLE 10 NORTH AMERICA: HPV TESTING MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 42
TABLE 11 ASIA-PACIFIC: HPV TESTING MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 42
TABLE 12 FOLLOW-UP HPV TESTING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 43
TABLE 13 HPV CO-TESTING MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 44
TABLE 14 PAP TEST MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 45
TABLE 15 PAP TEST MARKET SIZE, BY REGION, BY VOLUME 2013-2020 (MILLION TESTS) 46
TABLE 16 NORTH AMERICA: PAP TEST MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 46
TABLE 17 ASIA-PACIFIC: PAP TEST MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 46
TABLE 18 PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 48
TABLE 19 CERVICAL CANCER SCREENING MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 49
TABLE 20 NORTH AMERICA: CERVICAL CANCER SCREENING MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 50
TABLE 21 ASIA-PACIFIC: CERVICAL CANCER SCREENING MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 50
TABLE 22 VAGINAL CANCER SCREENING MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 51
TABLE 23 ASIA-PACIFIC: VAGINAL CANCER SCREENING MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 52
TABLE 24 HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 54
TABLE 25 HPV TESTING AND PAP TEST MARKET SIZE FOR LABORATORIES, BY REGION,
2013-2020 (USD MILLION) 56
TABLE 26 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE FOR LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION) 56
TABLE 27 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE FOR LABORATORIES,
BY COUNTRY, 2013-2020 (USD MILLION) 56
TABLE 28 HPV TESTING AND PAP TEST MARKET SIZE FOR HOSPITALS, BY REGION,
2013-2020 (USD MILLION) 57
TABLE 29 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE FOR HOSPITALS,
BY COUNTRY, 2013-2020 (USD MILLION) 58
TABLE 30 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE FOR HOSPITALS,
BY REGION/COUNTRY, 2013-2020 (USD MILLION) 58
TABLE 31 HPV TESTING AND PAP TEST MARKET SIZE FOR PHYSICIAN'S OFFICES
AND CLINICS, BY REGION, 2013-2020 (USD MILLION) 59
TABLE 32 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE FOR PHYSICIAN'S OFFICES AND CLINICS, BY COUNTRY, 2013-2020 (USD MILLION) 60
TABLE 33 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE FOR PHYSICIAN'S OFFICES AND CLINICS, BY COUNTRY, 2013-2020 (USD MILLION) 60
TABLE 34 HPV TESTING AND PAP TEST MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 64
TABLE 35 HPV TESTING AND PAP TEST MARKET SIZE, BY REGION,
2013-2020 (MILLION TESTS) 64
TABLE 36 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 67
TABLE 37 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 68
TABLE 38 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (MILLION TESTS) 68
TABLE 39 NORTH AMERICA: HPV TESTING MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 69
TABLE 40 NORTH AMERICA: PAP TEST MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 69
TABLE 41 NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 70
TABLE 42 U.S.: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 71
TABLE 43 U.S.: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 71
TABLE 44 U.S.: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 72
TABLE 45 CANADA: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 73
TABLE 46 CANADA: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 74
TABLE 47 CANADA: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 74
TABLE 48 EUROPE: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 77
TABLE 49 EUROPE: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (MILLION TESTS) 77
TABLE 50 EUROPE: HPV TESTING MARKET SIZE, BY TEST TYPE, 2013-2020 (USD MILLION) 77
TABLE 51 EUROPE: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 78
TABLE 52 EUROPE: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 79
TABLE 53 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 80
TABLE 54 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 81
TABLE 55 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (MILLION TESTS) 81
TABLE 56 ASIA-PACIFIC: HPV TESTING MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 81
TABLE 57 ASIA-PACIFIC: PAP TEST MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 82
TABLE 58 ASIA-PACIFIC: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 82
TABLE 59 JAPAN: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 82
TABLE 60 JAPAN: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 83
TABLE 61 JAPAN: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 83
TABLE 62 CHINA: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 84
TABLE 63 CHINA: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 85
TABLE 64 CHINA: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 85
TABLE 65 INDIA: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 86
TABLE 66 INDIA: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 86
TABLE 67 INDIA: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 87
TABLE 68 ROAPAC: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 87
TABLE 69 ROAPAC: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 88
TABLE 70 ROAPAC: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 88
TABLE 71 ROW: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (USD MILLION) 89
TABLE 72 ROW: HPV TESTING AND PAP TEST MARKET SIZE, BY TEST TYPE,
2013-2020 (MILLION TESTS) 89
TABLE 73 ROW: HPV TESTING MARKET SIZE, BY TEST TYPE, 2013-2020 (USD MILLION) 90
TABLE 74 ROW: PAP TEST MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 90
TABLE 75 ROW: HPV TESTING AND PAP TEST MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 91
TABLE 76 PRODUCT APPROVALS AND LICENSES 2013-2015 95
TABLE 77 NEW PRODUCT LAUNCHES, 2012-2015 96
TABLE 78 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2015 97
TABLE 79 ACQUISITIONS, 2012-2015 98
TABLE 80 EXPANSIONS, 2012-2015 99
LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 16
FIGURE 2 MARKET SIZE ESTIMATION AND DATA TRIANGULATION 18
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANIES, DESIGNATION,
AND REGION 19
FIGURE 4 HPV TESTING AND PAP TEST MARKET SNAPSHOT (2015 VS. 2020) 23
FIGURE 5 HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2015 VS. 2020 24
FIGURE 6 THE HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 24
FIGURE 7 CERVICAL CANCER SCREENING SEGMENT WILL CONTINUE TO DOMINATE THE PAP TEST MARKET DURING THE FORECAST PERIOD 25
FIGURE 8 NEW PRODUCT LAUNCH IS THE MOST DOMINANT STRATEGY ADOPTED BY MARKET PLAYERS 25
FIGURE 9 RISING INCIDENCES OF CERVICAL CANCER AND INCREASING AWARENESS OF CERVICAL CANCER SCREENING ARE FACTORS DRIVING MARKET GROWTH 26
FIGURE 10 HPV TESTING WILL BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 26
FIGURE 11 LABORATORIES SEGMENT DOMINATES THE HPV TESTING MARKET IN 2015 27
FIGURE 12 THE HPV TESTING AND PAP TEST MARKET IN NORTH AMERICA IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 27
FIGURE 13 HPV TESTING AND PAP TEST MARKET ANALYSIS 30
FIGURE 14 HPV TESTING AND PAP TEST MARKET: DRIVERS, RESTRAINTS, OPPORTUNITY,
AND CHALLENGE 31
FIGURE 15 CERVICAL CANCER INCIDENCES AND MORTALITY: GLOBAL FORECAST, 2012-2020 32
FIGURE 16 HPV TESTING SEGMENT TO OUTGROW PAP TESTING DURING THE FORECAST PERIOD 38
FIGURE 17 PRIMARY HPV TESTING SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING FORECAST PERIOD 40
FIGURE 18 NORTH AMERICA IS PROJECTED TO DOMINATE THE HPV TESTING MARKET DURING FORECAST PERIOD 41
FIGURE 19 NORTH AMERICA IS EXPECTED TO DOMINATE THE PAP TEST MARKET DURING THE FORECAST PERIOD 45
FIGURE 20 CERVICAL CANCER SCREENING IS A MAJOR APPLICATION OF THE HPV TESTING AND PAP TEST MARKET 48
FIGURE 21 NORTH AMERICA IS EXPECTED TO DOMINATE THE PAP TEST MARKET FOR CERVICAL CANCER SCREENING 49
FIGURE 22 NORTH AMERICA IS EXPECTED TO DOMINATE THE VAGINAL CANCER SCREENING MARKET 51
FIGURE 23 LABORATORIES ARE THE MAJOR END USERS OF THE HPV TESTING AND PAP TEST MARKET 54
FIGURE 24 NORTH AMERICA EXHIBITS HIGHEST GROWTH POTENTIAL IN THE LABORATORIES END USER SEGMENT 55
FIGURE 25 NORTH AMERICA IS PROJECTED TO DOMINATE THE HOSPITALS MARKET DURING THE FORECAST PERIOD 57
FIGURE 26 NORTH AMERICA: HIGHEST GROWTH POTENTIAL IN THE PHYSICIANS' OFFICES
AND CLINICS END-USER SEGMENT 59
FIGURE 27 GEOGRAPHIC SNAPSHOT: NORTH AMERICA WILL BE THE FASTEST-GROWING REGION IN THE HPV TESTING AND PAP TEST MARKET BY 2020 62
FIGURE 28 NORTH AMERICAN MARKET FOR HPV TESTING SHOWS SIGNIFICANT GROWTH OPPORTUNITIES 63
FIGURE 29 THE HPV TESTING AND PAP TEST MARKET IN NORTH AMERICA IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 63
FIGURE 30 NORTH AMERICA HPV TESTING AND PAP TEST MARKET SNAPSHOT 66
FIGURE 31 THE U.S. IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE NORTH AMERICA HPV TESTING AND PAP TEST MARKET DURING THE FORECAST PERIOD 67
FIGURE 32 THE FOLLOW-UP HPV TESTING SEGMENT IS EXPECTED TO DOMINATE THE NORTH AMERICA HPV TESTING MARKET 69
FIGURE 33 THE HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 71
FIGURE 34 THE HPV TESTING SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 73
FIGURE 35 EUROPEAN HPV TESTING AND PAP TEST MARKET SNAPSHOT 76
FIGURE 36 THE HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 78
FIGURE 37 JAPAN IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE IN THE ASIA-PACIFIC HPV TESTING AND PAP TEST MARKET 80
FIGURE 38 THE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2015 83
FIGURE 39 THE CERVICAL CANCER SCREENING SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2015 84
FIGURE 40 THE HPV TESTING SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 86
FIGURE 41 THE HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 88
FIGURE 42 THE HOSPITALS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 90
FIGURE 43 NEW PRODUCT LAUNCHES, PRODUCT APPROVALS, AGREEMENTS, AND ACQUISITIONS HAVE BEEN THE KEY STRATEGIES ADOPTED IN THE LAST
THREE YEARS 92
FIGURE 44 GLOBAL HPV TESTING AND PAP TEST MARKET SHARE, BY KEY PLAYERS, 2014 93
FIGURE 45 BATTLE FOR MARKET SHARE: PRODUCT APPROVALS AND LICENSES, NEW PRODUCT LAUNCH, AGREEMENTS and ACQUISITIONS HAVE BEEN THE KEY STRATEGIES 94
FIGURE 46 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS 100
FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT 101
FIGURE 48 QIAGEN N.V.: COMPANY SNAPSHOT 103
FIGURE 49 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 106
FIGURE 50 HOLOGIC, INC.: COMPANY SNAPSHOT 108
FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 111
FIGURE 52 QUEST DIAGNOSTICS: COMPANY SNAPSHOT 113

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 India Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2017 India Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

  • $ 3250
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging ...

2017 Hong Kong Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2017 Hong Kong Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

  • $ 3250
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging ...

2017 Bangladesh Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2017 Bangladesh Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

  • $ 3250
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.